Hans-jurgen J. Mager
Nieuwegein, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Engasertib in Hereditary Hemorrhagic Telangiectasia. Reply.
Journal: The New England journal of medicine
Published: February 18, 2026
Engasertib versus Placebo for Bleeding in Hereditary Hemorrhagic Telangiectasia.
Journal: The New England journal of medicine
Published: November 26, 2025
Publisher Correction: Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy.
Journal: Nature biomedical engineering
Published: August 12, 2025
Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centres.
Journal: British journal of clinical pharmacology
Published: June 11, 2025
Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report.
Journal: American journal of hematology
Published: June 09, 2025
Circulation of avian Chlamydia abortus in the Netherlands and community-acquired pneumonia: an outbreak investigation and retrospective cohort study.
Journal: The Lancet. Infectious diseases
Published: June 13, 2024
Conservative Pulmonary Arteriovenous Malformation Screening in Children: Re-Evaluation of Safety.
Journal: Pediatric pulmonology
Published: May 17, 2024
Pulmonary artery pseudoaneurysm after thoracic radiation therapy: A case report and review of the literature.
Journal: Respirology case reports
Published: March 14, 2024
Non-invasive characterization of pericyte dysfunction in mouse brain using functional ultrasound localization microscopy.
Journal: Nature biomedical engineering
Published: January 16, 2024
European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?
Journal: European journal of medical genetics
Published: November 30, 2021
Thresholds of Endoglin Expression in Endothelial Cells Explains Vascular Etiology in Hereditary Hemorrhagic Telangiectasia Type 1.
Journal: International journal of molecular sciences
Published: July 02, 2021
Last Updated: 09/26/2026